Diagnosis and Prognosis
November 4, 2023 2023-11-13 17:17Diagnosis and Prognosis
Research Goal
Since 2005 the UdS research groups of Prof. Keller, Prof. Lenhof, and Prof. Meese developed and published more than 30 novel approaches for the diagnosis and prognosis of diseases, e.g., for Alzheimer disease, different types of cancers, COPD, Multiples sclerosis, etc. Most of the approaches are based on antigen or miRNA pattern and apply machine learning methods (ML, AI).
General Approaches
Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity
•
RNA Biology (January 2, 2019)
Is there a general autoantibody signature for cancer?
•
European Journal of Cancer (October 1, 2012)
Toward the blood-borne miRNome of human diseases
•
Nature Methods (September 4, 2011)
Immunogenicity of autoantigens
•
BMC Genomics (July 4, 2011)
Large-scale antibody profiling of human blood sera: The future of molecular diagnosis
•
Informatik-Spektrum (August 1, 2009)
Alzheimer Disease
Machine Learning to Detect Alzheimer’s Disease from Circulating Non-coding RNAs
•
Genomics, Proteomics & Bioinformatics (December 4, 2019)
Cancer
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
•
JAMA Oncology (March 5, 2020)
Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development
•
Genomics Proteomics & Bioinformatics (June 1, 2018)
Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes
•
International Journal of Molecular Sciences (March 30, 2016)
Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades
•
Oncotarget (November 1, 2016)
Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase
•
Oncotarget (February 22, 2016)
Circulating serum miRNAs as potential biomarkers for nephroblastoma
•
Pediatr Blood Cancer (March 18, 2015)
Is there a general autoantibody signature for cancer?
•
European Journal of Cancer (October 1, 2012)
Multicenter study identified molecular blood-born protein signatures for Wilms Tumor
•
International Journal of Cancer (August 1, 2012)
Treatment-independent miRNA signature in blood of wilms tumor patients.
•
BMC Genomics (August 7, 2012)
Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis
•
RNA Biology (May 1, 2011)
Autoantibody signature differentiates wilms tumor patients from neuroblastoma patients
•
PLoS ONE (December 16, 2011)
Specific peripheral miRNA profiles for distinguishing lung cancer from COPD
•
Lung Cancer (March 8, 2011)
Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%
•
International Journal of Cancer (May 20, 2010)
High-throughput miRNA profiling of human melanoma blood samples
•
BMC Cancer (June 7, 2010)
Identification of lung cancer with high sensitivity and specificity by blood testing
•
Respiratory Research (February 10, 2010)
Improving Seroreactivity-Based Detection of Glioma
•
Neoplasia (December 11, 2009)
miRNAs in lung cancer – Studying complex fingerprints in patient’s blood cells by microrarray experiments
•
BMC Cancer (October 6, 2009)
Pattern of Serum Autoantibodies Allows Accurate Distinctionbetween aTumor and Pathologies of the Same Organ
•
Clinical Cancer Research (August 1, 2008)
Toward an early diagnosis of lung cancer: An autoantibody signature for squamous cell lung carcinoma
•
International Journal of Cancer (July 22, 2008)
Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation
•
PLoS ONE (May 14, 2008)
A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors
•
BMC Bioinformatics (December 21, 2006)
COPD
Low miR-150-5p and miR-320b Expression Predicts Reduced Survival of COPD Patients
•
Cells (September 27, 2019)
Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development
•
Genomics Proteomics & Bioinformatics (June 1, 2018)
Specific peripheral miRNA profiles for distinguishing lung cancer from COPD
•
Lung Cancer (March 8, 2011)
Novel autoantigens immunogenic in COPD patients
•
Respiratory Research (March 12, 2009)